Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

  1. Blanco, J.-R.
  2. Alejos, B.
  3. Moreno, S.
Zeitschrift:
PLoS ONE

ISSN: 1932-6203

Datum der Publikation: 2020

Ausgabe: 15

Nummer: 1

Art: Artikel

DOI: 10.1371/JOURNAL.PONE.0226724 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus